AR and breast carcinoma: Crabrolin-FR, crabrolin-AR, and crabrolin-PR with their increased number of charges, had lower anti-proliferative activities than crabrolin-TR, and the anti-proliferative activity of crabrolin-PR was relatively high (for example, for the human breast cancer (MCF-7) cells, its IC50 reached 12.29 μM).